Apimeds Pharmaceuticals Us, Inc. · AMEX:APUS
Inscobee Inc. reported a 16.70% stake in Apimeds Pharmaceuticals Us, Inc. (Schedule 13D/A)
Event Mar 20, 2026 · Filed Mar 20, 2026
Inscobee Inc. reported a 16.70% stake in Apimeds Pharmaceuticals Us, Inc., 2,099,747 shares, with active intent on Mar 20, 2026. Filed Mar 20, 2026 (Schedule 13D/A).
- Stake
- 16.70%
- Shares
- 2,099,747
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Inscobee Inc. | 16.70% | 2,099,747 |
| Apimeds Inc. | 34.30% | 4,316,618 |
Source
Related
- Apimeds Pharmaceuticals Us, Inc.
- Inscobee Inc.
- Apimeds Pharmaceuticals Us, Inc. shareholders
- Schedule 13D/A · Inscobee Inc. · May 7, 2026
- Schedule 13D/A · Inscobee Inc. · Mar 30, 2026
- Schedule 13D/A · Inscobee Inc. · Jan 26, 2026
- Schedule 13D · Inscobee Inc. · May 19, 2025
- Schedule 13G · Ayrton Capital LLC · Feb 11, 2026